Durham, NC 的 自體免疫疾病 臨床試驗
15 項針對 自體免疫疾病 的研究正在 Durham（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Environmental Risk Factors for the Anti-synthetase Syndrome
招募中觀察性研究歡迎健康志工
- NIEHS Clinical Research Unit (CRU), Research Triangle Park · 距離 7 英里
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
招募中3 期
- Duke University Hospital, Durham
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
招募中2/3 期
- Duke University Medical Center - Accepting Young Adults and Juvenile Patients, Durham
- University of North Carolina at Chapel Hill - Accepting Adult Patients, Chapel Hill · 距離 10 英里
Daratumumab in Primary Antiphospholipid Syndrome
招募中1/2 期
- Duke University, Durham
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
招募中1 期
- Duke University Medical Center, Durham
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
招募中3 期
- Duke University Hospital, Durham
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
招募中3 期
- GSK Investigational Site, Durham
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
招募中1/2 期
- UNC Chapel Hill, Chapel Hill · 距離 10 英里
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
招募中2/3 期
- Duke University, Durham
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
招募中3 期
- Duke University Medical Center, Durham
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
招募中3 期
- Site Number - 1013, Durham
- Site Number - 1020, Chapel Hill · 距離 10 英里
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
招募中1 期
- Duke University, Durham
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中觀察性研究
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 距離 10 英里
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
招募中1 期
- Duke University Health System, Durham
Maternal Autoimmune Disease Research Alliance (MADRA) Registry
招募中觀察性研究歡迎健康志工
- Duke University, Durham
其他城市的 自體免疫疾病 試驗
- Houston, TX21 項研究
- Washington, DC19 項研究
- New York City, NY19 項研究
- Philadelphia, PA16 項研究
- Boston, MA13 項研究
- Chicago, IL12 項研究
- Los Angeles, CA12 項研究
- Dallas, TX9 項研究
- Atlanta, GA8 項研究
- Portland, OR8 項研究
- Milwaukee, WI8 項研究
- Cleveland, OH8 項研究
Durham 的其他研究
- 乳癌64 項研究
- 癌症（所有類型）58 項研究
- 非小細胞肺癌39 項研究
- 多發性骨髓瘤37 項研究
- 急性髓系白血病33 項研究
- 轉移性癌症33 項研究
- 前列腺癌32 項研究
- 肺癌32 項研究
- 大腸直腸癌28 項研究
- 卵巢癌27 項研究
- 慢性淋巴性白血病27 項研究
- 心臟衰竭26 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。